Health Care·Health Care Services·$10.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.94 | N/A | +4.44% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.94 | N/A | +4.44% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to patient care. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering quality care to our patients.
DaVita's strong EPS performance indicates better-than-expected profitability, which likely contributed to the stock's significant rise of 11.83%. Investors reacted positively to the earnings beat, even though revenue figures were not disclosed. The management's focus on patient care suggests a stable operational strategy moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LOEWS CORP
Feb 9, 2009